Protein concentrations were determined by the Bradford method. Subsequently, an equal amount of concentrated unbound fraction from each healthy control (HC) sample and equal amounts of protein from each age-related macular degeneration (AMD) sample were mixed separately. Further details on the GELFrEE system can be obtained from publications by Tran et al 2, 3 . A total of 500 μg of protein was loaded onto a 1 cm gel column, cast to 12% T (with a 3-cm stacking gel cast to 4% T) and electrophoresed at 240 V for 2 h. Following elution of the dye front (fraction "zero"), additional collections were performed at 5, 15, 30, 50, and 120 min, yielding a total of five fractions.
Isoelectrofocusing of tryptic peptides
Ten GELFrEE fractions (five from HC and five from AMD) were adjusted to the same protein concentration, reduced with 10 mM DTT for 30 min at 37°C, and alkylated with 40 mM iodoacetamide for 1 h in the dark at 25°C. After the samples were diluted 10-fold with 50 mM NH 4 HCO 3 , trypsin was added at a ratio of 1:40 (w:w), followed by incubation overnight at 37°C. A 3100 OFFGEL Fractionator and OFFGEL Kit pH 3-10 (Agilent Technologies) in a 12-well format were used for isoelectrofocusing of the tryptic peptides. 
Reversed phase LC-MS/MS analysis

LC-MS/MS was performed on an
Quantification and statistical analysis
The relative abundance of identified proteins was estimated on the basis of spectral counts (the number of MS/MS spectra matched to the protein of interest). Spectral count data were extracted using the Protein Prophet program and exported to MS-EXCEL. Afterward, the normalized spectral abundance factor (NSAF) for each protein was obtained considering the total numbers of spectra for AMD patients and HCs (29,836 and 30,083, respectively) 4,5 . We calculated an NSAF for each protein as follows:
in which the total number of tandem MS spectra-matching peptides from protein k (SpC) was divided by the protein length (L) and then divided by the sum of SpC/L for all N proteins.
The abundance ratio for each protein was calculated as protein ratio = (average NSAF of the protein in AMD) / (average NSAF of the protein in HC).
In order to filter out differentially expressed proteins (DEPs) that were statistically significant, G-tests adjusted by the William"s correction were performed. The spectral counts for each protein were first normalized as where (SpC) i∈AMD and (SpC) i∈HC denote spectral counts of the i-th protein from the AMD and HC groups, respectively, and ∑ j∈AMD (SpC) j and ∑ k∈AMD (SpC) k are the total numbers of spectra. The G-value for the i-th protein was then calculated as follows:
A G-value higher than 3.841 was considered significant, with P < 0.05 according to the χ 2 -distribution 7 . In addition, the rank-sum test (Mann-Whitney test) was used to evaluated the difference in protein expression between AMD patients and HCs. All statistical analyses were performed using MedCalc (version 9.6.2.0, MedCalc Software, Ostend, Belgium).
